Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206308049> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4206308049 endingPage "S45" @default.
- W4206308049 startingPage "S45" @default.
- W4206308049 abstract "Our study aims to simulate the life-long cost of Immunoglobulin A Nephropathy (IgAN) to demonstrate its economic burden and quantify the potential cost savings resulting from improved care delivery in China A three-state (IgAN, End-stage renal disease/ESRD, Death) Markov model was developed to evaluate the total cost of IgAN in a life-long (45 years) time horizon from society perspective. The direct medical and non-medical cost including hospitalization, drugs, lab tests, transportation expenses etc. were obtained from published articles and national statistics website. The indirect cost including the productivity lose due to IgAN and ESRD were calculated based on national average GDP and working days lose due to the disease Using Markov model simulation, the life-long cumulated renal survival rate was 37.33%. The medical cost of IgAN and ESRD accounted for 78.08 % of total life-long cost. The indirect cost of IgAN and ESRD due to the productivity lose accounted for 21.92%. If the risk of progression to ESRD reduced 10%, 20%, 30% by new intervention compared to current IgAN treatment, 4, 8 and 14 years of ESRD will be delayed. The life-long cost of patients with IgAN imposes a tremendous economic burden in China healthcare system, which mainly comes from the medical cost after progression to ESRD. New therapies of IgAN may have both significant clinical and economic benefits from halting or delaying progression to ESRD." @default.
- W4206308049 created "2022-01-25" @default.
- W4206308049 creator A5009891554 @default.
- W4206308049 creator A5031340874 @default.
- W4206308049 creator A5032424847 @default.
- W4206308049 creator A5040913395 @default.
- W4206308049 creator A5056383449 @default.
- W4206308049 date "2022-01-01" @default.
- W4206308049 modified "2023-09-28" @default.
- W4206308049 title "POSA64 The Life-Long Economic Burden of Immunoglobulin A Nephropathy (IGAN) in China" @default.
- W4206308049 doi "https://doi.org/10.1016/j.jval.2021.11.209" @default.
- W4206308049 hasPublicationYear "2022" @default.
- W4206308049 type Work @default.
- W4206308049 citedByCount "0" @default.
- W4206308049 crossrefType "journal-article" @default.
- W4206308049 hasAuthorship W4206308049A5009891554 @default.
- W4206308049 hasAuthorship W4206308049A5031340874 @default.
- W4206308049 hasAuthorship W4206308049A5032424847 @default.
- W4206308049 hasAuthorship W4206308049A5040913395 @default.
- W4206308049 hasAuthorship W4206308049A5056383449 @default.
- W4206308049 hasBestOaLocation W42063080491 @default.
- W4206308049 hasConcept C121955636 @default.
- W4206308049 hasConcept C126322002 @default.
- W4206308049 hasConcept C134018914 @default.
- W4206308049 hasConcept C144133560 @default.
- W4206308049 hasConcept C177713679 @default.
- W4206308049 hasConcept C182299520 @default.
- W4206308049 hasConcept C2779134260 @default.
- W4206308049 hasConcept C2779922275 @default.
- W4206308049 hasConcept C2780091579 @default.
- W4206308049 hasConcept C2781184683 @default.
- W4206308049 hasConcept C2910852105 @default.
- W4206308049 hasConcept C3019040382 @default.
- W4206308049 hasConcept C555293320 @default.
- W4206308049 hasConcept C71924100 @default.
- W4206308049 hasConceptScore W4206308049C121955636 @default.
- W4206308049 hasConceptScore W4206308049C126322002 @default.
- W4206308049 hasConceptScore W4206308049C134018914 @default.
- W4206308049 hasConceptScore W4206308049C144133560 @default.
- W4206308049 hasConceptScore W4206308049C177713679 @default.
- W4206308049 hasConceptScore W4206308049C182299520 @default.
- W4206308049 hasConceptScore W4206308049C2779134260 @default.
- W4206308049 hasConceptScore W4206308049C2779922275 @default.
- W4206308049 hasConceptScore W4206308049C2780091579 @default.
- W4206308049 hasConceptScore W4206308049C2781184683 @default.
- W4206308049 hasConceptScore W4206308049C2910852105 @default.
- W4206308049 hasConceptScore W4206308049C3019040382 @default.
- W4206308049 hasConceptScore W4206308049C555293320 @default.
- W4206308049 hasConceptScore W4206308049C71924100 @default.
- W4206308049 hasIssue "1" @default.
- W4206308049 hasLocation W42063080491 @default.
- W4206308049 hasOpenAccess W4206308049 @default.
- W4206308049 hasPrimaryLocation W42063080491 @default.
- W4206308049 hasRelatedWork W1540807578 @default.
- W4206308049 hasRelatedWork W1839838842 @default.
- W4206308049 hasRelatedWork W2034395835 @default.
- W4206308049 hasRelatedWork W2082025651 @default.
- W4206308049 hasRelatedWork W2101340420 @default.
- W4206308049 hasRelatedWork W2261756287 @default.
- W4206308049 hasRelatedWork W2443266550 @default.
- W4206308049 hasRelatedWork W2789945271 @default.
- W4206308049 hasRelatedWork W2969125856 @default.
- W4206308049 hasRelatedWork W1672161162 @default.
- W4206308049 hasVolume "25" @default.
- W4206308049 isParatext "false" @default.
- W4206308049 isRetracted "false" @default.
- W4206308049 workType "article" @default.